Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan.
Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan.
Frank B. Cortazar,J. Niles,5 Authors,P. Bekker
2023 · DOI: 10.1016/j.ekir.2023.01.039
Kidney International Reports · 45 Citations
TLDR
This new analysis examines the results in the patient subgroup with severe renal insufficiency at enrollment into the ADVOCATE trial, i.e., eGFR improved more in the avacopan group than in the prednisone group.